Literature DB >> 17510239

Corticosterone inhibits the lipid-mobilizing effects of oleoyl-estrone in adrenalectomized rats.

Maria del Mar Grasa1, Marta Serrano, José Antonio Fernández-López, Marià Alemany.   

Abstract

Oleoyl-estrone (OE) is an adipose-derived signal that decreases energy intake and body lipid, maintaining energy expenditure and glycemic homeostasis. Glucocorticoids protect body lipid and the metabolic status quo. We studied the combined effects of OE and corticosterone in adrenalectomized female rats: daily OE gavages (0 or 10 nmol/g) and slow-release corticosterone pellets at four doses (0, 0.5, 1.7, and 4.8 mg/d). Intact and sham-operated controls were also included. After 8 d, body composition and plasma metabolites and hormones were measured. OE induced a massive lipid mobilization (in parallel with decreased food intake and maintained energy expenditure). Corticosterone increased fat deposition and inhibited the OE-elicited mobilization of body energy, even at the lowest dose. OE enhanced the corticosterone-induced rise in plasma triacylglycerols, and corticosterone blocked the OE-induced decrease in leptin. High corticosterone and OE increased insulin resistance beyond the effects of corticosterone alone. The presence of corticosterone dramatically affected OE effects, reversing its decrease of body energy (lipid) content, with little or no change on food intake or energy expenditure. The maintenance of glycemia and increasing insulin in parallel to the dose of corticosterone indicate a decrease in insulin sensitivity, which is enhanced by OE. The reversal of OE effects on lipid handling, insulin resistance, can be the consequence of a corticosterone-induced OE resistance. Nevertheless, OE effects on cholesterol were largely unaffected. In conclusion, corticosterone administration effectively blocked OE effects on body lipid and energy balance as well as insulin sensitivity and glycemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510239     DOI: 10.1210/en.2007-0331

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Mathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosing.

Authors:  Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; Debra C Dubois; Richard R Almon; William J Jusko
Journal:  Mol Pharm       Date:  2008-02-14       Impact factor: 4.939

2.  Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?

Authors:  Marià Alemany
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-27       Impact factor: 5.555

3.  Corticosteroid-Binding Globulin is expressed in the adrenal gland and its absence impairs corticosterone synthesis and secretion in a sex-dependent manner.

Authors:  José Gulfo; Ricard Castel; Angelo Ledda; María Del Mar Romero; Montserrat Esteve; Mar Grasa
Journal:  Sci Rep       Date:  2019-09-30       Impact factor: 4.379

4.  New Roles for Corticosteroid Binding Globulin and Opposite Expression Profiles in Lung and Liver.

Authors:  Jose Gulfo; Angelo Ledda; Sabrina Gea-Sorlí; Laia Bonjoch; Daniel Closa; Mar Grasa; Montserrat Esteve
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.